Scientific journal
Научное обозрение. Медицинские науки
ISSN 2500-0780
ПИ №ФС77-57452

THE PLACEBO CONTROLLED STUDY OF THEEFFICACY OF THE ALPHA RHYTHM SPECTRUM POWER ENHANCEMENT NEUROFEEDBACK PROTOCOL IN THEATHLETES OF HIGH QUALIFICATION: THE ESTIMATION OFTHE COMBINED PRIMARY ENDPOINT

Eremeev S.I. 1 Eremeeva O.V. 1 Kormilets V.S. 1
1 Khanty-Mansiysk state medical academy
We have done the placebo controlled study of theefficacyof theneurofeedback protocol of the alpha rhythm spectrum power enhancement in the C3A1monopolar lead in the athletes of high qualification. Design of the survey was prospective randomized monocentric single-blind comparative placebo-controlled study. The combined primary endpoint of the efficacyestimation was the sum of number of cases of sport results positive dynamic and number of cases without sport results dynamic. The study included 134 athletes of high qualification. By the method of lottery randomization 122 participants were included in the neurofeedback group and 12 participants were included in the placebo group. The neurofeedback intervention was based on Peniston protocol. We have obtained data that proved the greater efficiency of themodified neurofeedback protocolby comparison with placebo in the athletes of high qualification.The analysis of the placebo and the neurofeedback groups on the McNemar Χ2 criterion revealed significant differences in the frequency of primary endpoint (Χ2 A/D = 79,04 p<0,001; Χ2 B/C = 69,48 p<0,001).